» Articles » PMID: 9508323

Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas Aeruginosa Isolates from Patients with Long-term Bladder Catheterization

Overview
Specialty Microbiology
Date 1998 Mar 21
PMID 9508323
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The E test was evaluated in comparison with reference agar methods (National Committee for Clinical Laboratory Standards) for the susceptibility testing of 248 Pseudomonas aeruginosa isolates from bladder-catheterized patients against nine antibiotics. The E-test MICs correlated well with those determined by the agar dilution and disk diffusion reference methods (88 and 92.5% within 1 log2 dilution step, respectively), confirming that the E test is a reliable method for the determination of MICs of antibiotics for catheterization-associated P. aeruginosa isolates.

Citing Articles

Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods.

Elbehiry A, Marzouk E, Abalkhail A, Abdelsalam M, Mostafa M, Alasiri M Front Microbiol. 2025; 16:1549044.

PMID: 40071214 PMC: 11893576. DOI: 10.3389/fmicb.2025.1549044.


Occurrence, antimicrobial susceptibility, and pathogenic factors of in canine clinical samples.

Hattab J, Mosca F, Di Francesco C, Aste G, Marruchella G, Guardiani P Vet World. 2021; 14(4):978-985.

PMID: 34083949 PMC: 8167523. DOI: 10.14202/vetworld.2021.978-985.


Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts.

Frimodt-Moller J, Rossi E, Haagensen J, Falcone M, Molin S, Krogh Johansen H Sci Rep. 2018; 8(1):12512.

PMID: 30131514 PMC: 6104031. DOI: 10.1038/s41598-018-30972-y.


Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.

Mokaddas E, Salako N, Philip L, Rotimi V J Clin Microbiol. 2007; 45(7):2162-5.

PMID: 17475751 PMC: 1932995. DOI: 10.1128/JCM.00063-07.


Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Balke B, Hogardt M, Schmoldt S, Hoy L, Weissbrodt H, Haussler S Eur J Clin Microbiol Infect Dis. 2006; 25(1):25-30.

PMID: 16402226 DOI: 10.1007/s10096-005-0076-9.


References
1.
Masuda N, Ohya S . Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1992; 36(9):1847-51. PMC: 192198. DOI: 10.1128/AAC.36.9.1847. View

2.
Fish D, Piscitelli S, Danziger L . Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy. 1995; 15(3):279-91. View

3.
Turnidge J . Epidemiology of quinolone resistance. Eastern hemisphere. Drugs. 1995; 49 Suppl 2:43-7. DOI: 10.2165/00003495-199500492-00008. View

4.
Marley E, Mohla C, Campos J . Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol. 1995; 33(12):3191-3. PMC: 228671. DOI: 10.1128/jcm.33.12.3191-3193.1995. View

5.
Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M . Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol. 1997; 35(7):1842-6. PMC: 229853. DOI: 10.1128/jcm.35.7.1842-1846.1997. View